| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |